You SJ - Search Results

1

PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature.

Xiao J, Hu CP, He BX, Chen X, Lu XX, Xie MX, Li W, He SY, You SJ, Chen Q. Xiao J, et al. Among authors: you sj. Oncotarget. 2016 Sep 6;7(36):57832-57840. doi: 10.18632/oncotarget.11068. Oncotarget. 2016. PMID: 27506936 Free PMC article. Review.

2

The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.

Xiao J, Zou Y, Chen X, Gao Y, Xie M, Lu X, Li W, He B, He S, You S, Chen Q. Xiao J, et al. PLoS One. 2016 Apr 1;11(4):e0152674. doi: 10.1371/journal.pone.0152674. eCollection 2016. PLoS One. 2016. PMID: 27035914 Free PMC article.

3

Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysis.

Xiao J, He B, Zou Y, Chen X, Lu X, Xie M, Li W, He S, You S, Chen Q. Xiao J, et al. Sci Rep. 2016 Jul 26;6:30437. doi: 10.1038/srep30437. Sci Rep. 2016. PMID: 27457567 Free PMC article. Review.

4

Membrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective study.

Xie M, Zhu X, Liu Z, Shrubsole M, Varma V, Mayer IA, Dai Q, Chen Q, You S. Xie M, et al. PLoS One. 2012;7(4):e35198. doi: 10.1371/journal.pone.0035198. Epub 2012 Apr 4. PLoS One. 2012. PMID: 22496908 Free PMC article.

5

Progesterone inhibits the migration and invasion of A549 lung cancer cells through membrane progesterone receptor α-mediated mechanisms.

Xie M, You S, Chen Q, Chen X, Hu C. Xie M, et al. Oncol Rep. 2013 May;29(5):1873-80. doi: 10.3892/or.2013.2336. Epub 2013 Mar 6. Oncol Rep. 2013. PMID: 23467643

6

Progesterone and Src family inhibitor PP1 synergistically inhibit cell migration and invasion of human basal phenotype breast cancer cells.

Xie M, Zhou L, Chen X, Gainey LO, Xiao J, Nanes MS, Hou A, You S, Chen Q. Xie M, et al. Biomed Res Int. 2015;2015:426429. doi: 10.1155/2015/426429. Epub 2015 May 17. Biomed Res Int. 2015. Retraction in: Biomed Res Int. 2022 Apr 8;2022:9810368. doi: 10.1155/2022/9810368 PMID: 26075237 Free PMC article. Retracted.

7

mPRα mediates P4/Org OD02-0 to improve the sensitivity of lung adenocarcinoma to EGFR-TKIs via the EGFR-SRC-ERK1/2 pathway.

Lu X, Guan A, Chen X, Xiao J, Xie M, Yang B, He S, You S, Li W, Chen Q. Lu X, et al. Mol Carcinog. 2020 Feb;59(2):179-192. doi: 10.1002/mc.23139. Epub 2019 Nov 28. Mol Carcinog. 2020. PMID: 31777985

8

Progesterone/Org inhibits lung adenocarcinoma cell growth via membrane progesterone receptor alpha.

Xiao J, Chen X, Lu X, Xie M, He B, He S, You S, Chen Q. Xiao J, et al. Thorac Cancer. 2020 Aug;11(8):2209-2223. doi: 10.1111/1759-7714.13528. Epub 2020 Jun 11. Thorac Cancer. 2020. PMID: 32529777 Free PMC article.

9

Administration of nanodrugs in proper menstrual stage for maximal drug retention in breast cancer.

You S, Li W. You S, et al. Med Hypotheses. 2008;71(1):141-7. doi: 10.1016/j.mehy.2007.12.018. Epub 2008 Mar 4. Med Hypotheses. 2008. PMID: 18299174

10

Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway.

Zuo L, Li W, You S. Zuo L, et al. Breast Cancer Res. 2010;12(3):R34. doi: 10.1186/bcr2588. Epub 2010 Jun 11. Breast Cancer Res. 2010. PMID: 20540763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters